fig6
![ImmuneScore as a novel RNA-based prognostic signature superior to PD-L1 in advanced non-squamous NSCLC patients receiving chemotherapy combined with immune checkpoint inhibitor therapy](https://image.oaes.cc/cbfa8ca1-48a6-4f3c-807e-c3fc79a72622/jcmt100139.fig.6.jpg)
Figure 6. Significant KEGG signaling pathways involved in the high versus low ImmuneScore group. Several immune-associated pathways were enriched in the high ImmuneScore group, which were highlighted with yellow frame border.
Figure 6. Significant KEGG signaling pathways involved in the high versus low ImmuneScore group. Several immune-associated pathways were enriched in the high ImmuneScore group, which were highlighted with yellow frame border.
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/